AML1 and the AML1-ETO fusion protein in the pathogenesis of t(8;21) AML. (Q34405452)

2 August 2017

1 reference

title

AML1 and the AML1-ETO fusion protein in the pathogenesis of t(8;21) AML. (English)

1 reference

2 August 2017

Licht JD

1

1 reference

PubMed ID

11607817

2 August 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

2 August 2017

1 reference

2 August 2017

20

1 reference

2 August 2017

40

1 reference

2 August 2017

5660-5679

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1204593

2 August 2017

0 references

cites work

The leukemic protein core binding factor beta (CBFbeta)-smooth-muscle myosin heavy chain sequesters CBFalpha2 into cytoskeletal filaments and aggregates

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Crystal structure of the BTB domain from PLZF

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Negative regulation of granulocytic differentiation in the myeloid precursor cell line 32Dcl3 by ear-2, a mammalian homolog of Drosophila seven-up, and a chimeric leukemogenic gene, AML1/ETO.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Molecular detection of t(8;21)/AML1-ETO in AML M1/M2: correlation with cytogenetics, morphology and immunophenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Groucho-dependent and -independent repression activities of Runt domain proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Identification of an upstream enhancer containing an AML1 site in the human myeloperoxidase (MPO) gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

The Ig fold of the core binding factor alpha Runt domain is a member of a family of structurally and functionally related Ig-fold DNA-binding domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Associations between morphology, karyotype, and clinical features in myeloid leukemias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Core binding factor cannot synergistically activate the myeloperoxidase proximal enhancer in immature myeloid cells without c-Myb

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

ALY, a context-dependent coactivator of LEF-1 and AML-1, is required for TCRalpha enhancer function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

CBFA2T1, a gene rearranged in human leukemia, is a member of a multigene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Sodium butyrate inhibits histone deacetylation in cultured cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Failure of embryonic hematopoiesis and lethal hemorrhages in mouse embryos heterozygous for a knocked-in leukemia gene CBFB-MYH11.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

The leukemia-associated gene TEL encodes a transcription repressor which associates with SMRT and mSin3A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

The WW domain of Yes-associated protein binds a proline-rich ligand that differs from the consensus established for Src homology 3-binding modules

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

The capacity of polyomavirus enhancer binding protein 2alphaB (AML1/Cbfa2) to stimulate polyomavirus DNA replication is related to its affinity for the nuclear matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

ETO-2, a new member of the ETO-family of nuclear proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Identification of two transcripts of AML1/ETO-fused gene in t(8;21) leukemic cells and expression of wild-type ETO gene in hematopoietic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Both TEL and AML-1 contribute repression domains to the t(12;21) fusion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

The t(8;21) fusion protein, AML1/ETO, transforms NIH3T3 cells and activates AP-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Overexpression of AML1 renders a T hybridoma resistant to T cell receptor-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Aberrant recruitment of the nuclear receptor corepressor-histone deacetylase complex by the acute myeloid leukemia fusion partner ETO.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Expression of the human acute myeloid leukemia gene AML1 is regulated by two promoter regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Assembly and function of a TCR alpha enhancer complex is dependent on LEF-1-induced DNA bending and multiple protein-protein interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Auto-inhibition of Ets-1 is counteracted by DNA binding cooperativity with core-binding factor alpha2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Molecular insights into PEBP2/CBF beta-SMMHC associated acute leukemia revealed from the structure of PEBP2/CBF beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Drosophila homologs of the proto-oncogene product PEBP2/CBF beta regulate the DNA-binding properties of Runt

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

HERF1, a novel hematopoiesis-specific RING finger protein, is required for terminal differentiation of erythroid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

In vivo analysis of the molecular pathogenesis of acute promyelocytic leukemia in the mouse and its therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Dimerization with PEBP2beta protects RUNX1/AML1 from ubiquitin-proteasome-mediated degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Solution structure of core binding factor beta and map of the CBF alpha binding site

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Inhibition of the transforming growth factor beta 1 signaling pathway by the AML1/ETO leukemia-associated fusion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

The Drosophila segmentation gene runt encodes a novel nuclear regulatory protein that is also expressed in the developing nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Intrinsic transcriptional activation-inhibition domains of the polyomavirus enhancer binding protein 2/core binding factor alpha subunit revealed in the presence of the beta subunit

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Cytoplasmic sequestration of the polyomavirus enhancer binding protein 2 (PEBP2)/core binding factor alpha (CBFalpha) subunit by the leukemia-related PEBP2/CBFbeta-SMMHC fusion protein inhibits PEBP2/CBF-mediated transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

AML1, the target of chromosomal rearrangements in human leukemia, regulates the expression of human complement receptor type 1 (CR1) gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Mutual activation of Ets-1 and AML1 DNA binding by direct interaction of their autoinhibitory domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

The AML1-MTG8 leukemic fusion protein forms a complex with a novel member of the MTG8(ETO/CDR) family, MTGR1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Interaction and functional cooperation of the leukemia-associated factors AML1 and p300 in myeloid cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

The AML1/ETO fusion protein activates transcription of BCL-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Block of granulocytic differentiation of 32Dcl3 cells by AML1/ETO(MTG8) but not by highly expressed Bcl-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Association of MTG8 (ETO/CDR), a leukemia-related protein, with serine/threonine protein kinases and heat shock protein HSP90 in human hematopoietic cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Real-time quantitative reverse transcription-polymerase chain reaction for the detection of AML1-MTG8 fusion transcripts in t(8;21)-positive acute myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Structure and Function in the Nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

A large variety of alternatively spliced and differentially expressed mRNAs are encoded by the human acute myeloid leukemia gene AML1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Transcriptional repression by AML1 and LEF-1 is mediated by the TLE/Groucho corepressors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

AML1, AML2, and AML3, the human members of the runt domain gene-family: cDNA structure, expression, and chromosomal localization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

AML1 (CBFalpha2) cooperates with B cell-specific activating protein (BSAP/PAX5) in activation of the B cell-specific BLK gene promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Acquisition of oncogenic potential by RAR chimeras in acute promyelocytic leukemia through formation of homodimers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

A novel ubiquitin-specific protease, UBP43, cloned from leukemia fusion protein AML1-ETO-expressing mice, functions in hematopoietic cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy chain in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Oncogenic transcription factors in the human acute leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Subcellular localization of the alpha and beta subunits of the acute myeloid leukemia-linked transcription factor PEBP2/CBF

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

The inv(16) encodes an acute myeloid leukemia 1 transcriptional corepressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

The MYND motif is required for repression of basal transcription from the multidrug resistance 1 promoter by the t(8;21) fusion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

A mechanism of repression by acute myeloid leukemia-1, the target of multiple chromosomal translocations in acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

ETO, a target of t(8;21) in acute leukemia, interacts with the N-CoR and mSin3 corepressors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Functional and physical interactions between AML1 proteins and an ETS protein, MEF: implications for the pathogenesis of t(8;21)-positive leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Ribozymes cleave the AML1/MTG8 fusion transcript and inhibit proliferation of leukemic cells with t(8;21).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

The mammalian basic helix loop helix protein HES-1 binds to and modulates the transactivating function of the runt-related factor Cbfa1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Association with the nuclear matrix and interaction with Groucho and RUNX proteins regulate the transcription repression activity of the basic helix loop helix factor Hes1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

The t(8;21) chromosomal translocation in acute myelogenous leukemia modifies intranuclear targeting of the AML1/CBFalpha2 transcription factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

In-depth mutational analysis of the promyelocytic leukemia zinc finger BTB/POZ domain reveals motifs and residues required for biological and transcriptional functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

The ETO protein disrupted in t(8;21)-associated acute myeloid leukemia is a corepressor for the promyelocytic leukemia zinc finger protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Identification of AML-1 and the (8;21) translocation protein (AML-1/ETO) as sequence-specific DNA-binding proteins: the runt homology domain is required for DNA binding and protein-protein interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

The t(8;21) fusion protein interferes with AML-1B-dependent transcriptional activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Oligomerization of RAR and AML1 transcription factors as a novel mechanism of oncogenic activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Quantitative acute leukemia cytogenetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

AML1/ETO-expressing nonleukemic stem cells in acute myelogenous leukemia with 8;21 chromosomal translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Alternative splicing and genomic structure of the AML1 gene involved in acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Structure and expression pattern of a human MTG8/ETO family gene, MTGR1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

The AML1 transcription factor functions to develop and maintain hematogenic precursor cells in the embryonic aorta-gonad-mesonephros region.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Immunoglobulin motif DNA recognition and heterodimerization of the PEBP2/CBF Runt domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Indispensable role of the transcription factor PEBP2/CBF in angiogenic activity of a murine endothelial cell MSS31.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Hematopoiesis in the fetal liver is impaired by targeted mutagenesis of a gene encoding a non-DNA binding subunit of the transcription factor, polyomavirus enhancer binding protein 2/core binding factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Transcriptionally active chimeric gene derived from the fusion of the AML1 gene and a novel gene on chromosome 8 in t(8;21) leukemic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Cloning and gene mapping of the mouse homologue of the CBFA2T1 gene associated with human acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

PEBP2/CBF, the murine homolog of the human myeloid AML1 and PEBP2 beta/CBF beta proto-oncoproteins, regulates the murine myeloperoxidase and neutrophil elastase genes in immature myeloid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Nuclear import and subnuclear localization of the proto-oncoprotein ETO (MTG8)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Molecular cloning and characterization of PEBP2 beta, the heterodimeric partner of a novel Drosophila runt-related DNA binding protein PEBP2 alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and the human AML1 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

AML1(-/-) embryos do not express certain hematopoiesis-related gene transcripts including those of the PU.1 gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Biological characteristics of the leukemia-associated transcriptional factor AML1 disclosed by hematopoietic rescue of AML1-deficient embryonic stem cells by using a knock-in strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Multiple functional domains of AML1: PU.1 and C/EBPalpha synergize with different regions of AML1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Transcription-coupled translation control of AML1/RUNX1 is mediated by cap- and internal ribosome entry site-dependent mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Polyomavirus enhancer-binding protein 2/core binding factor/acute myeloid leukemia factors contribute to the cell type-specific activity of the CD11a integrin gene promoter.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Synergistic up-regulation of the myeloid-specific promoter for the macrophage colony-stimulating factor receptor by AML1 and the t(8;21) fusion protein may contribute to leukemogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Growth inhibition and induction of differentiation of t(8;21) acute myeloid leukemia cells by the DNA-binding domain of PEBP2 and the AML1/MTG8(ETO)-specific antisense oligonucleotide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Absence of fetal liver hematopoiesis in mice deficient in transcriptional coactivator core binding factor beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Expression of the Runt domain-encoding PEBP2 alpha genes in T cells during thymic development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Histone deacetylase inhibitors: novel anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Expression of the AML-1 oncogene shortens the G(1) phase of the cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Tumourigenicity of MTG8, a leukaemia-related gene, in concert with v-Ha-ras gene in BALB/3T3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

A role for hematopoietic stem cells in promoting angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Increased expression of AML1 during retinoic-acid-induced differentiation of U937 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

The extracellular signal-regulated kinase pathway phosphorylates AML1, an acute myeloid leukemia gene product, and potentially regulates its transactivation ability

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

The CBFbeta subunit is essential for CBFalpha2 (AML1) function in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Cloning and characterization of subunits of the T-cell receptor and murine leukemia virus enhancer core-binding factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Structural basis for the heterodimeric interaction between the acute leukaemia-associated transcription factors AML1 and CBFbeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

The t(8;21) fusion product, AML-1-ETO, associates with C/EBP-alpha, inhibits C/EBP-alpha-dependent transcription, and blocks granulocytic differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Polymorphism in the 3' untranslated region of MTG8 is associated with obesity in Pima Indian males

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Structure and expression of the human MTG8/ETO gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Components of the SMRT corepressor complex exhibit distinctive interactions with the POZ domain oncoproteins PLZF, PLZF-RARalpha, and BCL-6

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Atrophin-1, the dentato-rubral and pallido-luysian atrophy gene product, interacts with ETO/MTG8 in the nuclear matrix and represses transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

A WW domain-containing yes-associated protein (YAP) is a novel transcriptional co-activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Embryonic lethality and impairment of haematopoiesis in mice heterozygous for an AML1-ETO fusion gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Leukemia translocation protein PLZF inhibits cell growth and expression of cyclin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Intranuclear targeting of AML/CBFalpha regulatory factors to nuclear matrix-associated transcriptional domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Identification of a nuclear matrix targeting signal in the leukemia and bone-related AML/CBF-alpha transcription factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Identification of a region which directs the monocytic activity of the colony-stimulating factor 1 (macrophage colony-stimulating factor) receptor promoter and binds PEBP2/CBF (AML1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

CCAAT enhancer-binding protein (C/EBP) and AML1 (CBF alpha2) synergistically activate the macrophage colony-stimulating factor receptor promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Oligomerization of ETO is obligatory for corepressor interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Transcriptional regulation of the transforming growth factor-beta -inducible mouse germ line Ig alpha constant region gene by functional cooperation of Smad, CREB, and AML family members.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

A novel transcript encoding an N-terminally truncated AML1/PEBP2 alphaB protein interferes with transactivation and blocks granulocytic differentiation of 32Dcl3 myeloid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

TLE, the Human Homolog of Groucho, Interacts with AML1 and Acts as a Repressor of AML1-Induced Transactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Architecture and anatomy of the genomic locus encoding the human leukemia-associated transcription factor RUNX1/AML1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

Alignment of U3 region sequences of mammalian type C viruses: identification of highly conserved motifs and implications for enhancer design

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

7 January 2021

Polyclonal haemopoieses associated with long-term persistence of the AML1-ETO transcript in patients with FAB M2 acute myeloid leukaemia in continous clinical remission

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

7 January 2021

Diminution of the AML1 transcription factor function causes differential effects on the fates of CD4 and CD8 single-positive T cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

7 January 2021

Regulation of c-fos gene transcription and myeloid cell differentiation by acute myeloid leukemia 1 and acute myeloid leukemia-MTG8, a chimeric leukemogenic derivative of acute myeloid leukemia 1

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

7 January 2021

Purification of a mouse nuclear factor that binds to both the A and B cores of the polyomavirus enhancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

7 January 2021

Real-time RT-PCR for the detection and quantification of AML1/MTG8 fusion transcripts in t(8;21)-positive AML patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

7 January 2021

Incidence of AML1/ETO fusion transcripts in patients entered into the MRC AML trials. MRC Adult Leukaemia Working Party

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

7 January 2021

Detection of minimal residual disease in patients with AML1/ETO-associated acute myeloid leukemia using a novel quantitative reverse transcription polymerase chain reaction assay

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

7 January 2021

Leukemia-associated AML1/ETO (8;21) chromosomal translocation protein increases the cellular representation of PML bodies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

7 January 2021

Quantitative analysis of AML1/ETO transcripts in peripheral blood stem cell harvests from patients with t(8;21) acute myelogenous leukaemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

7 January 2021

Glucocorticoids induce apoptosis in acute myeloid leukemia cell lines with A t(8;21) chromosome translocation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

7 January 2021

Identification of the region of mi transcription factor which is responsible for the synergy with PEBP2/CBF

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

7 January 2021

Evaluation of minimal residual disease using reverse-transcription polymerase chain reaction in t(8;21) acute myeloid leukemia: a multicenter study of 51 patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

7 January 2021

Serial quantification of minimal residual disease of t(8;21) acute myelogenous leukaemia with RT-competitive PCR assay

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

7 January 2021

Smad and AML proteins synergistically confer transforming growth factor beta1 responsiveness to human germ-line IgA genes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

7 January 2021

Rapid disappearance of AML1/ETO fusion transcripts in patients with t(8;21) acute myeloid leukemia following bone marrow transplantation and chemotherapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

7 January 2021

AML1-MTG16 fusion gene in therapy-related acute leukemia with t(16;21)(q24;q22); two new cases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

7 January 2021

Disappearance of AML1-MTG8(ETO) fusion transcript in acute myeloid leukaemia patients with t(8;21) in long-term remission

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

7 January 2021

Expression of AML1/MTG8 transcripts in clonogenic cells grown from bone marrow of patients in remission of acute myeloid leukaemia with t(8;21)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

7 January 2021

Detection of t(8;21) by reverse transcriptase polymerase chain reaction in patients in remission of acute myeloid leukaemia type M2 after chemotherapy or bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

7 January 2021

MDS1/EVI1 enhances TGF-beta1 signaling and strengthens its growth-inhibitory effect but the leukemia-associated fusion protein AML1/MDS1/EVI1, product of the t(3;21), abrogates growth-inhibition in response to TGF-beta1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

7 January 2021

Quantitation of minimal residual disease in t(8;21)-positive acute myelogenous leukemia patients using real-time quantitative RT-PCR

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

7 January 2021

An acute myeloid leukemia gene, AML1, regulates hemopoietic myeloid cell differentiation and transcriptional activation antagonistically by two alternative spliced forms.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

7 January 2021

Crystal structure of the nuclear matrix targeting signal of the transcription factor acute myelogenous leukemia-1/polyoma enhancer-binding protein 2alphaB/core binding factor alpha2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

7 January 2021

t(8;21) breakpoints are clustered between alternatively spliced exons of MTG8

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

7 January 2021

A full-length Cbfa1 gene product perturbs T-cell development and promotes lymphomagenesis in synergy with myc

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204593

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1204593

1 reference

PubMed ID

11607817

Dimensions Publication ID

2 August 2017

0 references

1 reference

PubMed ID

11607817